Partner

Noelle Dubiansky is a partner in the firm’s Technology and Life Sciences groups.

Ms. Dubiansky represents biotechnology, pharmaceutical, medical device, and other life science companies in a wide range of intellectual property and commercial transactions. She regularly advises private and public companies on complex commercial transactions, including strategic partnerships, licensing, technology acquisition, research and development collaborations, clinical testing, contract services, distribution and manufacturing agreements. Ms. Dubiansky also regularly counsels clients in connection with private financings, public offerings, spin-outs and M&A transactions with respect to intellectual property rights and operational risks.

Prior to joining Goodwin, Ms. Dubiansky was an associate in the Life Sciences practice group at Cooley LLP and previously, in the FDA group at Hyman, Phelps & McNamara. She joined Goodwin in 2014.

While attending law school, Ms. Dubiansky was named an Edward F. Hennessey Scholar.

JD, Intellectual Property Concentration, 2005, Boston University School of Law (honors) / BA, Biology, 1999, Boston University